Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

The Effects of Metformin and Weight Loss on Biomarkers Associated With Breast Cancer Outcomes.

Patterson RE, Marinac CR, Sears DD, Kerr J, Hartman SJ, Cadmus-Bertram L, Villaseñor A, Flatt SW, Godbole S, Li H, Laughlin GA, Oratowski-Coleman J, Parker BA, Natarajan L.

J Natl Cancer Inst. 2018 Nov 1;110(11):1239-1247. doi: 10.1093/jnci/djy040.

PMID:
29788487
2.

Recruitment strategies, design, and participant characteristics in a trial of weight-loss and metformin in breast cancer survivors.

Patterson RE, Marinac CR, Natarajan L, Hartman SJ, Cadmus-Bertram L, Flatt SW, Li H, Parker B, Oratowski-Coleman J, Villaseñor A, Godbole S, Kerr J.

Contemp Clin Trials. 2016 Mar;47:64-71. doi: 10.1016/j.cct.2015.12.009. Epub 2015 Dec 17.

3.

Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: An Updated Systematic Review for the U.S. Preventive Services Task Force [Internet].

LeBlanc EL, Patnode CD, Webber EM, Redmond N, Rushkin M, O’Connor EA.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Sep.

4.

Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.

Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, Fiorini S, Cognigni GE, Filicori M, Morselli-Labate AM.

J Clin Endocrinol Metab. 2000 Aug;85(8):2767-74.

PMID:
10946879
5.

Effect of metformin vs placebo on and metabolic factors in NCIC CTG MA.32.

Goodwin PJ, Parulekar WR, Gelmon KA, Shepherd LE, Ligibel JA, Hershman DL, Rastogi P, Mayer IA, Hobday TJ, Lemieux J, Thompson AM, Pritchard KI, Whelan TJ, Mukherjee SD, Chalchal HI, Oja CD, Tonkin KS, Bernstein V, Chen BE, Stambolic V.

J Natl Cancer Inst. 2015 Mar 4;107(3). pii: djv006. doi: 10.1093/jnci/djv006. Print 2015 Mar.

6.

Metformin for overweight women at midlife: a double-blind, randomized, controlled trial.

Worsley R, Jane F, Robinson PJ, Bell RJ, Davis SR.

Climacteric. 2015 Apr;18(2):270-7. doi: 10.3109/13697137.2014.954997. Epub 2014 Oct 21.

PMID:
25333776
7.

Favorable changes in serum estrogens and other biologic factors after weight loss in breast cancer survivors who are overweight or obese.

Rock CL, Pande C, Flatt SW, Ying C, Pakiz B, Parker BA, Williams K, Bardwell WA, Heath DD, Nichols JF.

Clin Breast Cancer. 2013 Jun;13(3):188-95. doi: 10.1016/j.clbc.2012.12.002. Epub 2013 Jan 29.

8.

Sex hormone changes during weight loss and maintenance in overweight and obese postmenopausal African-American and non-African-American women.

Stolzenberg-Solomon RZ, Falk RT, Stanczyk F, Hoover RN, Appel LJ, Ard JD, Batch BC, Coughlin J, Han X, Lien LF, Pinkston CM, Svetkey LP, Katki HA.

Breast Cancer Res. 2012 Oct 31;14(5):R141. doi: 10.1186/bcr3346.

9.

Phase II study of metformin for reduction of obesity-associated breast cancer risk: a randomized controlled trial protocol.

Martinez JA, Chalasani P, Thomson CA, Roe D, Altbach M, Galons JP, Stopeck A, Thompson PA, Villa-Guillen DE, Chow HH.

BMC Cancer. 2016 Jul 19;16:500. doi: 10.1186/s12885-016-2551-3.

10.

Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial.

Wu RR, Zhao JP, Jin H, Shao P, Fang MS, Guo XF, He YQ, Liu YJ, Chen JD, Li LH.

JAMA. 2008 Jan 9;299(2):185-93. doi: 10.1001/jama.2007.56-b.

PMID:
18182600
11.

Endogenous sex hormone changes in postmenopausal women in the diabetes prevention program.

Kim C, Kong S, Laughlin GA, Golden SH, Mather KJ, Nan B, Edelstein SL, Randolph JF Jr, Labrie F, Buschur E, Barrett-Connor E.

J Clin Endocrinol Metab. 2012 Aug;97(8):2853-61. doi: 10.1210/jc.2012-1233. Epub 2012 Jun 11.

12.

The association of elective hormone therapy with changes in lipids among glucose intolerant postmenopausal women in the diabetes prevention program.

Golden SH, Kim C, Barrett-Connor E, Nan B, Kong S, Goldberg R; Diabetes Prevention Program Research Group.

Metabolism. 2013 Sep;62(9):1313-22. doi: 10.1016/j.metabol.2013.04.005. Epub 2013 May 6.

13.

Effects of initiating insulin and metformin on glycemic control and inflammatory biomarkers among patients with type 2 diabetes: the LANCET randomized trial.

Pradhan AD, Everett BM, Cook NR, Rifai N, Ridker PM.

JAMA. 2009 Sep 16;302(11):1186-94. doi: 10.1001/jama.2009.1347.

PMID:
19755697
14.

The effects of metformin on endogenous androgens and SHBG in women: a systematic review and meta-analysis.

Barba M, Schünemann HJ, Sperati F, Akl EA, Musicco F, Guyatt G, Muti P.

Clin Endocrinol (Oxf). 2009 May;70(5):661-70. doi: 10.1111/j.1365-2265.2008.03459.x. Epub 2008 Oct 21.

PMID:
19178532
15.

Effects of diet composition on weight loss, metabolic factors and biomarkers in a 1-year weight loss intervention in obese women examined by baseline insulin resistance status.

Rock CL, Flatt SW, Pakiz B, Quintana EL, Heath DD, Rana BK, Natarajan L.

Metabolism. 2016 Nov;65(11):1605-1613. doi: 10.1016/j.metabol.2016.07.008. Epub 2016 Jul 25.

16.

Effect of a low fat versus a low carbohydrate weight loss dietary intervention on biomarkers of long term survival in breast cancer patients ('CHOICE'): study protocol.

Sedlacek SM, Playdon MC, Wolfe P, McGinley JN, Wisthoff MR, Daeninck EA, Jiang W, Zhu Z, Thompson HJ.

BMC Cancer. 2011 Jul 6;11:287. doi: 10.1186/1471-2407-11-287.

17.

Effect of Metformin Added to Insulin on Glycemic Control Among Overweight/Obese Adolescents With Type 1 Diabetes: A Randomized Clinical Trial.

Libman IM, Miller KM, DiMeglio LA, Bethin KE, Katz ML, Shah A, Simmons JH, Haller MJ, Raman S, Tamborlane WV, Coffey JK, Saenz AM, Beck RW, Nadeau KJ; T1D Exchange Clinic Network Metformin RCT Study Group.

JAMA. 2015 Dec 1;314(21):2241-50. doi: 10.1001/jama.2015.16174.

18.

Metformin for treatment of antipsychotic-induced amenorrhea and weight gain in women with first-episode schizophrenia: a double-blind, randomized, placebo-controlled study.

Wu RR, Jin H, Gao K, Twamley EW, Ou JJ, Shao P, Wang J, Guo XF, Davis JM, Chan PK, Zhao JP.

Am J Psychiatry. 2012 Aug;169(8):813-21. doi: 10.1176/appi.ajp.2012.11091432.

PMID:
22711171
19.

Reduced-calorie dietary weight loss, exercise, and sex hormones in postmenopausal women: randomized controlled trial.

Campbell KL, Foster-Schubert KE, Alfano CM, Wang CC, Wang CY, Duggan CR, Mason C, Imayama I, Kong A, Xiao L, Bain CE, Blackburn GL, Stanczyk FZ, McTiernan A.

J Clin Oncol. 2012 Jul 1;30(19):2314-26. doi: 10.1200/JCO.2011.37.9792. Epub 2012 May 21.

20.

Effect of metformin compared with hypocaloric diet on serum C-reactive protein level and insulin resistance in obese and overweight women with polycystic ovary syndrome.

Esfahanian F, Zamani MM, Heshmat R, Moini nia F.

J Obstet Gynaecol Res. 2013 Apr;39(4):806-13. doi: 10.1111/j.1447-0756.2012.02051.x. Epub 2012 Dec 21.

PMID:
23279603

Supplemental Content

Support Center